SUGI Holdings Co., Ltd.

Greenhouse gas emissions & sustainability report data

๐Ÿ“Š Latest report period: 2023๐Ÿ—‚๏ธ Report periods on file: 2023, 2021-03-01 to 2022-02-28, 2020-03 to 2021-02

In its 2023 reporting, SUGI Holdings Co., Ltd. disclosed greenhouse gas emissions of 135.1K t-CO2 (FY2023). By scope: Scope 3: 1.7M t-CO2 (FY2022). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

๐Ÿ’จ
GHG Emissions
135.1K t-CO2 (FY2023)
2023
๐Ÿ’ง
Water Usage
755.0K m3/year
2023
โš™๏ธ
Energy Use
314.3K thousand kWh/year
2023

๐Ÿ“Š Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).1.7M t-CO2 (FY2022)

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

๐Ÿ“ˆ Emissions by Report Period

Report periodHeadline emissions figure reported
2023135.1K t-CO2 (FY2023)
2021-03-01 to 2022-02-28To be measured

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

โœ… Reported Environmental Achievements

๐ŸŽฏ Climate & Sustainability Targets

๐Ÿ”œ Short-term

  • Increase the percentage of stores equipped with AEDs to 20% by the end of FY2025.
  • Achieve a yearly total of 250,000 users for the home-visit prescription dispensing service by the end of FY2025.
  • Raise the engagement index to 3.5 by the end of FY2024, and 4.0 in the long term.

๐Ÿ“… Medium-term

  • Increase the ratio of female managers to 30% by the end of FY2029.
  • Reduce CO2 emissions per store by 50% by FY2030 compared to FY2014.
  • Increase the percentage of eco-friendly private brand products to 30% by 2030.

๐Ÿ”ญ Long-term

  • Net zero emissions by 2050.

๐ŸŒฑ ESG Focus Areas

Healthy CommunitySustainable Business PartnershipContribution to the Global EnvironmentHealthy Workplace EnvironmentCorporate Governance

โš ๏ธ Challenges & Risks +

  • Continuing shortage of pharmacists.
  • Intensifying competition in the drugstore industry leading to an oligopoly.
  • Severe year-on-year revision of dispensing fees.
  • Need to reduce CO2 emissions from Scope 3 (supply chain).
  • Declining birthrate, aging population, and shrinking population leading to declining domestic consumption.

๐Ÿ“‹ Report Information

Reporting Period: 2023
Frameworks: GRI, SASB, TCFD